Good MorningEquity markets advanced the previous week as economic and earnings trends lifted the market. The move was driven by better-than-expected results from NVIDIA and many retailers, including Walmart, Lowe's, and TJX Companies. The takeaway is that the consumer remains resilient, and the outlook for Q4 is likely low. The consensus is a low-single-digit increase in holiday quarter sales, sufficient to set a record.
Next week is a holiday-shortened week; the market is closed Thursday for Thanksgiving. The critical resistance point for the S&P 500 is near 6,100 and may be reached soon. A move above that level would signal a continuation of the market trends and a likelihood of a substantial gain in 2025. In that scenario, the S&P 500 could rise by another 1,300 basis points before topping out. Featured: Sell these "safe" blue chips immediately (Ad) 
|
Finance | |
Emerging market stocks can be particularly difficult to understand. However, there is evidence that those who do understand this part of the market can reap benefits. A 2023 study confirmed the belief that stock markets in developed countries are more efficient than those in emerging ones. This me... Read the Full Story |
|
From Our Partners | | Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief.
It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. | | Watch the full story and see the verified track record for yourself |
|
Communication Services | |
The Walt Disney Company (NYSE: DIS) needs little introduction. From its iconic animated films and beloved theme parks to its expansive television networks and quickly evolving streaming platforms, Disney holds a unique place in the global entertainment sector. Disney’s stock has seen a rec... Read the Full Story |
|
Technology | |
The technology sector has been the focus of attention lately, with a special focus on the semiconductor industry and its biggest stories. Out of all the businesses centered in this space, two have commanded the most attention today, for good and bad reasons alike.
NVIDIA Co. (NASDAQ: NVDA) has be... Read the Full Story |
|
From Our Partners | | Moderna's stock doubled in a single day after its cancer vaccine hit key Phase 3 goals, and Merck jumped too. But according to a former Steve Cohen fund manager, the next big opportunity is not Moderna or Merck.
It is a different kind of company tied to a technology already backed by Elon Musk, Sam Altman, Jeff Bezos, and Peter Thiel. Nvidia's Jensen Huang says it will have a dramatic impact on daily life, while Anthropic's CEO believes it could unlock a century of medical progress in just ten years.
Nature Magazine estimates its potential value at $367 trillion globally, and it is already rolling out across the United States. | | Click here to learn about this new era of medical technology |
|
Industrials | |
Vertiv Holdings Co. (NYSE: VRT) has experienced a remarkable surge over the past year, but its stock price jumped approximately 15% in a single day following a well-received investor event. This significant price movement, coupled with a flurry of Vertiv Holding’s analyst community upgrades ... Read the Full Story |
|
Consumer Discretionary | |
Tesla Inc. (NASDAQ: TSLA) stock has been up 56.2% since Donald Trump was elected president of the United States. But the recent move of 6.6% the week of November 18, 2024, has investors thinking that the stock may be going to $400 or even higher.
News broke that the Trump administration is pla... Read the Full Story |
|
From Our Partners | | Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required.
Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. | | Discover the gold income fund before the next payout date |
|
Technology | |
Most of the stock market’s attention has been directed to cryptocurrency, the hottest and most popular niche of the technology sector today. The idea behind most decisions is that, as the price of Bitcoin keeps rallying near an all-time high of $100,000 per coin, most—if not all—... Read the Full Story |
|
Technology | |
Snowflake (NYSE: SNOW) shares wallowed near long-term lows for years as concerns about slowing growth and financial health weighed on sentiment, but the times have changed. The Q3 results reveal persistent strength, swelling client counts, and depending penetration of services, revealing its indus... Read the Full Story |
|
Communication Services | |
Netflix (NASDAQ: NFLX) recently jumped into the ring of live sports broadcasting with the Mike Tyson vs. Jake Paul boxing match. This new offering from Netflix marks a significant shift from its established on-demand content model. While the event drew record-breaking viewership, it also exposed... Read the Full Story |
|
Energy | |
Plenty of vertical industries will see increases in volatility when and if oil prices begin to move away from the cyclical lows they currently trade at. While some investors might see volatility as potentially dangerous, those who have been in the stock market long enough understand that volatilit... Read the Full Story |
|
Industrials | |
Symbotic (NASDAQ: SYM) is a revolutionary robotics company whose stock is on the rise big time over the past three months. Shares are up 52% over that period. Despite that, shares are still down nearly 30% through all of 2024. A big contributor to the company’s recent rise is its Q4 earnin... Read the Full Story |
|
Monday's Early Bird Stock Of The Day Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. | | View Today's Stock Pick |
|
